| 7064 |
Howtelevision, Inc.
|
Other |
|
Financial Results for the First Quarter of the Fiscal Year Ending January 2027 (Consolidated, Japanese Standards)
|
Jun 10, 2026
|
| 7064 |
Howtelevision, Inc.
|
Other |
|
Financial Results for the First Quarter of the Fiscal Year Ending January 2027 (Consolidated, Japanese GAAP)
|
Jun 10, 2026
|
| 7049 |
SHIKIGAKU. Co., Ltd.
|
Other |
|
Notice Regarding the Conclusion of a Loan Agreement with Financial Covenants
|
Jun 10, 2026
|
| 7046 |
Ｇ－ＴＤＳＥ
|
Other |
|
Publication of Q&A Session from Our Financial Results Briefing
|
Jun 10, 2026
|
| 5976 |
High Frequency Heat Treatment Co., Ltd.
|
Share Buyback |
|
Share Buyback Executed | May 2026
|
Jun 10, 2026
|
| 5644 |
Metalart Corporation
|
Other |
|
Notice of Correction Regarding the Public Tender Offer Commencement Announcement Due to Submission of Corrected Public Tender Offer Notification by Gerbera Holdings Inc.
|
Jun 10, 2026
|
| 5032 |
Nijisanji
|
Earnings |
|
2026 Fiscal Year Full-Year Financial Results Explanation Materials
|
Jun 10, 2026
|
| 5032 |
ANYCOLOR Inc.
|
Earnings |
|
[ANYCOLOR] Fiscal Year 2026 Results｜Sales of ¥5.57 billion (29.9% increase)
|
Jun 10, 2026
|
| 5031 |
Moi Corporation
|
Other |
|
Consolidated Financial Results for the First Quarter of the Fiscal Year Ending January 2027 (Japanese GAAP)
|
Jun 10, 2026
|
| 5031 |
Moi Corporation
|
Other |
|
First Quarter Financial Results Summary for the Fiscal Term Ending January 2027 (Japanese GAAP, Non-Consolidated)
|
Jun 10, 2026
|
| 4880 |
CellSource Co., Ltd.
|
Other |
|
Notice Regarding Recognition of Non-Operating Expenses
|
Jun 10, 2026
|
| 4880 |
CellSource Co., Ltd.
|
Other |
|
Notice Regarding the Recording of Non-Operating Expenses
|
Jun 10, 2026
|
| 4880 |
CellSource Co., Ltd.
|
Other |
|
Notice Regarding the Recording of Non-Operating Expenses
|
Jun 10, 2026
|
| 4599 |
StemRIM
|
Other |
|
Financial Results for the Third Quarter of the Fiscal Year Ending July 2026 (Japanese Standards) [Non-Consolidated]
|
Jun 10, 2026
|
| 4565 |
NexeraPharma Corporation
|
Strategy |
|
【NexeraPharma】AI Drug Discovery Collaboration and Business Strategy｜June 2026
|
Jun 10, 2026
|
| 4556 |
KAINOS Laboratories, Inc.
|
Other |
|
Notice of Delisting of Our Company’s Shares
|
Jun 10, 2026
|
| 4496 |
Commerce One Holdings Inc.
|
Other |
|
Notice of Results and Completion of Share Buyback Program
|
Jun 10, 2026
|
| 4463 |
Nicca Chemical Co.,Ltd.
|
Other |
|
Notice Regarding Changes in the Company President (Resignation) and Replacement of the Cosmetics Division Head
|
Jun 10, 2026
|
| 4040 |
Nankai Chemical Company,Limited
|
Other |
|
Financial Results Briefing Materials for the Fiscal Year Ending March 2026
|
Jun 10, 2026
|
| 4014 |
Karadanote, Inc.
|
Other |
|
Q3 Fiscal Year Ending July 2026 Financial Results Explanation Materials
|
Jun 10, 2026
|
